Dietrich W. Beelen

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

Robert Zeiser, Andreas Burchert, Claudia Lengerke et al. · Leukemia · 2015 · 540 citations · Full text

Medicine, Clinical Sciences, Immunology +16

Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation

Cristina Toffalori, Laura Zito, Valentina Gambacorta et al. · Nature Medicine · 2019 · 402 citations · Full text

Life Sciences, Hematology, Immunology +16

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

Rüdiger Hehlmann, Michael Lauseker, Susanne Saußele et al. · Leukemia · 2017 · 339 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients

Ahmet Elmaağaclı, Nina K. Steckel, Michael Koldehoff et al. · Blood · 2011 · 314 citations · Full text

Life Sciences, Immunology, Oncology +17

Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia

ZiYi Lim, Ronald Brand, Rodrigo Martino et al. · Journal of Clinical Oncology · 2009 · 305 citations · Full text

Medicine, Hematology, Hematologic Oncology +16